The proposed technical solution describes the kit for the determination of blood serum copper binding capacity and analytical set containing afore-mentioned kit for determining pyruvaldehyde in blood serum suitable for the early diagnosis of diabetes or anastomosis dehiscence after colorectal cancer surgery.